Rational design of effective therapy combining irinotecan and rapamycin to target mTOR/HIF-1 alpha axis in colon cancer

被引：0
|
作者：
Pencreach, E. [1 ]
Arrive, M. [1 ]
Raffelsberger, W. [2 ]
Lelong-Rebel, I. [3 ]
Larsen, A. K. [4 ]
Gaub, M. P. [1 ]
Guenot, D. [1 ]
Guerin, E. [1 ]
机构：
[1] INSERM, U682, Mol Biol Lab, Strasbourg, France
[2] IGBMC, Integrat Bioinformat Dept, Strasbourg, France
[3] CNRS, EA ULP 3430, Strasbourg, France
[4] INSERM, U893, Paris, France
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(08)72527-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：185 / 185
页数：1
相关论文
共 39 条
  • [31] Holothuria scabraExtract Induces Cell Apoptosis and Suppresses Warburg Effect by Down-Regulating Akt/mTOR/HIF-1 Axis in MDA-MB-231 Breast Cancer Cells
    Yurasakpong, Laphatrada
    Apisawetakan, Somjai
    Pranweerapaiboon, Kanta
    Sobhon, Prasert
    Chaithirayanon, Kulathida
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2021, 73 (10): : 1964 - 1975
  • [32] AKT-AMPKα-mTOR-dependent HIF-1α Activation is a New Therapeutic Target for Cancer Treatment: A Novel Approach to Repositioning the Antidiabetic Drug Sitagliptin for the Management of Hepatocellular Carcinoma
    Abd El-Fattah, Eslam E.
    Saber, Sameh
    Youssef, Mahmoud E.
    Eissa, Hanan
    El-Ahwany, Eman
    Amin, Noha A.
    Alqarni, Mohammed
    Batiha, Gaber El-Saber
    Obaidullah, Ahmad J.
    Kaddah, Mohamed M. Y.
    Gaafar, Ahmed Gaafar Ahmed
    Mourad, Ahmed A. E.
    Mostafa-Hedeab, Gomaa
    Abdelhamid, Amir Mohamed
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [33] MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells
    Katayoon Pakravan
    Sadegh Babashah
    Majid Sadeghizadeh
    Seyed Javad Mowla
    Majid Mossahebi-Mohammadi
    Farangis Ataei
    Nasim Dana
    Mohammad Javan
    Cellular Oncology, 2017, 40 : 457 - 470
  • [34] Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1α via the mTOR/p70S6K/4E-BP1 and MAPK pathways
    Mi, Chunliu
    Ma, Juan
    Wang, Ke Si
    Zuo, Hong Xiang
    Wang, Zhe
    Li, Ming Yue
    Piao, Lian Xun
    Xu, Guang Hua
    Li, Xuezheng
    Quan, Zhe Shan
    Jin, Xuejun
    JOURNAL OF ETHNOPHARMACOLOGY, 2017, 203 : 27 - 38
  • [35] MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells
    Pakravan, Katayoon
    Babashah, Sadegh
    Sadeghizadeh, Majid
    Mowla, Seyed Javad
    Mossahebi-Mohammadi, Majid
    Ataei, Farangis
    Dana, Nasim
    Javan, Mohammad
    CELLULAR ONCOLOGY, 2017, 40 (05) : 457 - 470
  • [36] miR-224 aggravates cancer-associated fibroblast-induced progression of non-small cell lung cancer by modulating a positive loop of the SIRT3/AMPK/mTOR/HIF-1α axis
    Zhang, Juan
    Han, Lan
    Yu, Jing
    Li, Hui
    Li, Qingfeng
    AGING-US, 2021, 13 (07): : 10431 - 10449
  • [37] Cryptotanshinone inhibits the growth and invasion of colon cancer by suppressing inflammation and tumor angiogenesis through modulating MMP/TIMP system, PI3K/Akt/mTOR signaling and HIF-1α nuclear translocation
    Zhang, Lin
    Chen, Chang
    Duanmu, Jiaxin
    Wu, Yan
    Tao, Jinhua
    Yang, Aihua
    Yin, Xiaoqin
    Xiong, Biao
    Gu, Jingya
    Li, Chunling
    Liu, Zhaoguo
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 65 : 429 - 437
  • [38] Vanillic Acid Suppresses HIF-1 Expression via Inhibition of mTOR/p70S6K/4E-BP1 and Raf/MEK/ERK Pathways in Human Colon Cancer HCT116 Cells
    Gong, Jingli
    Zhou, Shengxue
    Yang, Shihai
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (03):
  • [39] A synergistic combination strategy for optimal inhibition of colon cancer stem cells: Simultaneous inhibition of Insulin-like growth factor-1 receptor-AKT-mammalian target of rapamycin axis and the mevalonate-isoprenoid biosynthetic pathway
    Sharon, Chetna
    Boothello, Rio
    Vera, Alberto
    Patel, Bhaumik B.
    CANCER RESEARCH, 2019, 79 (13)
1234